Irinotecan (CPT-11) in Patients with Advanced Colon Carcinoma Relapsing after 5-Fluorouracil-Leucovorin Combination

Publisher： Karger

E-ISSN： 1421-9794|48|2|94-99

ISSN： 0009-3157

Source： Chemotherapy, Vol.48, Iss.2, 2002-05, pp. : 94-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sequential Administration of 5-Fluorouracil (5FU)/Leucovorin (LV) Followed by Irinotecan (CPT-11) at Relapse versus CPT-11 Followed by 5-FU/LV in Advanced Colorectal Carcinoma

By  

Chemotherapy, Vol. 53, Iss. 4, 2007-05 ,pp. : 282-291

Karger

Access to resources Recommend Favorite

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy

By  

Chemotherapy, Vol. 59, Iss. 4, 2014-01 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Irinotecan Combined with Infusional 5-Fluorouracil and High-Dose Leucovorin for the Treatment of Advanced Gastric Carcinoma as the First-Line Chemotherapy

By  

Chemotherapy, Vol. 52, Iss. 5, 2006-08 ,pp. : 264-270

Karger

Access to resources Recommend Favorite

The Irinotecan/5-Fluorouracil Combination Induces Apoptosis and Enhances Manganese Superoxide Dismutase Activity in HT-29 Human Colon Carcinoma Cells

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 93-102

Karger

Access to resources Recommend Favorite

Gemcitabine Combined with Infusional 5-Fluorouracil and High-Dose Leucovorin for the Treatment of Advanced Carcinoma of the Pancreas

By  

Chemotherapy, Vol. 50, Iss. 3, 2004-06 ,pp. : 127-132

Karger

Access to resources Recommend Favorite